CIBC World Markets’s AstraZeneca AZN Stock Holding History

CIBC World Markets’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.61M	Buy	+14,178	New	+$2.49M	0.01%	559
2025 Q2	$2.97M	Buy	+21,226	New	+$2.97M	0.02%	479
2025 Q1	–	Sell	-6,451	Closed	-$845K	–	1849
2024 Q4	$845K	Buy	6,451 +71	+1%	+$9.94K	﹤0.01%	630
2024 Q3	$994K	Sell	6,380 -14,676	-70%	-$2.37M	0.01%	617
2024 Q2	$3.28M	Buy	21,056 +1,884	+10%	+$284K	0.02%	397
2024 Q1	$2.6M	Sell	19,172 -22,620	-54%	-$3M	0.02%	445
2023 Q4	$5.63M	Buy	41,792 +8,284	+25%	+$1.08M	0.03%	317
2023 Q3	$4.54M	Buy	33,508 +8,726	+35%	+$1.19M	0.04%	253
2023 Q2	$3.55M	Buy	24,782 +21,165	+585%	+$3.11M	0.03%	362
2023 Q1	$502K	Sell	3,617 -15	-0.4%	-$2.02K	0.01%	587
2022 Q4	$492K	Buy	+3,632	New	+$455K	﹤0.01%	633
2022 Q3	–	Sell	-16,101	Closed	-$2.13M	–	562
2022 Q2	$2.13M	Buy	16,101 +7,844	+95%	+$1.03M	0.02%	378
2022 Q1	$1.09M	Buy	+8,257	New	+$990K	0.01%	500

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC World Markets's AZN Position: Q4 2025 in Review

CIBC World Markets opened a new position in AstraZeneca (AZN) in Q4 2025: 14,178 shares worth $2.61M. The stake represents 0.01% of the portfolio and ranks #559 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in AZN as recently as Q2 2025.

CIBC World Markets first reported a position in AZN in Q1 2022 and has held it in 13 quarters since. The position peaked at $5.63M in Q4 2023. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

CIBC World Markets held 14,178 shares of AstraZeneca worth $2.61M as of Q4 2025.
AstraZeneca was a new CIBC World Markets position in Q4 2025.
AstraZeneca made up 0.01% of CIBC World Markets's portfolio in Q4 2025, its #559 holding.
CIBC World Markets first reported a position in AstraZeneca in Q1 2022 and has held it in 13 quarters since.
CIBC World Markets's AstraZeneca position peaked at $5.63M in Q4 2023.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.